全球脸部注射剂市场规模（按产品、应用、地区、范围和预测）

脸部注射剂的市场规模及预测

2021 年脸部注射剂市场规模价值 5,746,0.5 亿美元，预计到 2030 年将达到 23,448,2.3 亿美元，2023 年至 2030 年的复合年增长率为 16.91%。脸部填充物最常见的用途是减少老化的早期迹象并增强美感。胶原蛋白、玻尿酸、聚合物和肉毒桿菌毒素是最常用的脸部注射剂。脸部注射疗法在减少皮肤皱纹、使皮肤光滑、丰唇、去除皱纹、治疗痤疮、治疗疤痕等方面的流行，正在推动脸部注射剂的市场应用，我们正在这样做。在即将进行的研究中，美国 FDA 正在考虑批准使用脸部填充物治疗声带麻痹，这预计将促进脸部填充物市场的成长。

脸部填充剂的全球市场定义

真皮填充剂是另一个脸部注射剂的名称。脸部注射剂包括胶原蛋白、羟基磷灰石钙和透明质酸类治疗，可发挥多种功效，包括去除或减少皱纹、丰唇、提升疤痕和减少软组织体积。脸部填充物用于填充目标区域，有助于减少脸部皱纹和瑕疵。抗皱注射剂可以放鬆引起皱纹的肌肉，而真皮填充剂可以减少皱纹并增加脸颊和嘴唇的体积。

皮肤填充剂直接注射到皱纹中，而抗皱纹注射剂则放鬆产生皱纹的肌肉。填充剂由糖分子或透明质酸、胶原蛋白（从猪、牛、尸体中提取或在实验室合成）、患者的脂肪和合成聚合物组成。羟基磷灰石钙、聚酰胺、聚丙烯酸酯和聚乳酸就是后者的例子。 Artiste 辅助注射系统于 2012 年引进美国市场，用于辅助注射真皮填充剂。

透过控制临床医生使用填充物填充嘴唇和鬓角的速率，注射器装置可以减少患者的不适和不良事件。瘀青、发红、不适和搔痒都是皮肤填充手术失败的常见副作用。感染和过敏反应是造成疤痕或肿瘤的不常见原因。在极少数情况下，曾报告过因眼静脉或视网膜静脉逆行（突然）栓塞而促使失明等严重副作用。

该产业正在利用技术突破。目前正在利用先进的技术创新开发抗氧化皮肤贴片。贴片底部采用微针穿透皮肤，使抗氧化剂渗透到皮肤深层。这些贴片可能是一种更好、更快的在家中舒缓和提亮皮肤的方法。这款贴片富含抗氧化剂，可充分发挥其潜力，为我们提供抚平皱纹、亮白肌肤的功效。这为该行业带来了各种未来机会。

脸部填充剂全球市场概况

人们发现，脸部注射剂市场正在蓬勃发展，规模也不断成长。非手术市场治疗、脸部注射填充剂和减少皱纹注射均增加了三倍。预计预测期内非侵入性美容手术将推动市场成长。污染和多种生活方式的选择会促使皮肤损伤，从而在预测期内增加需求。胶原纤维、透明质酸填充剂、合成填充剂等可用作脸部注射。这款乳霜可以滋润和强化皮肤，同时保护皮肤免受紫外线的伤害并最大限度地减少其有害影响。

脸部注射剂市场受上述所有标准驱动。此外，整形外科医生及其网路的崛起推动了对整容手术的需求，从而增加了对脸部注射剂的需求。 FDA 也批准包括牙医在内的其他从业人员在其诊所中使用脸部填充剂。由于牙医会遇到许多在牙科治疗后需要进行脸部重塑的患者，因此他们现在可以进行脸部注射手术。因此，脸部注射剂市场可能会得到发展。

此外，治疗方法和材料的进步以及患者人口结构的变化正在帮助医生和皮肤科医生治疗各种面部区域。这些创新有助于医生和皮肤科医生为患者制定个人化治疗方案，使使用组合产品获得更好效果变得更加容易，并推动了全球脸部注射剂的成长。预计所有这些因素都将促进市场未来的成长。与 HA（透明质酸）和 BoNTA（A 型肉毒桿菌）填充剂等放大产品结合使用，可改善效果，尤其是在下脸部过程中。

这也有助于扩大全球脸部填充剂市场。脸部注射剂的生产能力、关键市场参数、年成长率以及製造商市场占有率都是影响行业机会的方面。由于对严格规定、物品限制以及皮疹和发红等皮肤问题的担忧，其增长受到限制。与美学应用相比，未来几年市场扩张预计还会受到多种市场限制的阻碍。填充剂价格过高，限制了扩张，从而缩小了市场规模。皮肤填充剂的不良反应也是限制脸部注射剂业务规模的一个主要问题。

目录

第 1 章：全球脸部注射剂市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章：脸部注射剂的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型

第 5 章全球脸部注射剂市场（按产品划分）

• 概述
• A 型肉毒桿菌毒素
• 羟基磷灰石钙 (CaHA)
• 胶原蛋白
• 玻尿酸 (HA)
• 聚合物填料

第6章 全球脸部注射剂市场（依应用）

• 概述 治疗
• 美容

第7章 全球脸部注射剂市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章全球脸部注射剂市场：竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第9章 公司简介

• Suneva Medical, Inc.
• ALLERGAN
• Bloomage BioTechnology Corporation Limited
• Ipsen
• Merz Pharma
• Anika Therapeutics, Inc.
• Medytox, Inc.
• Galderma S.A.
• Prollenium Medical Technologies Inc.
• Sinclair Pharma

第 10 章 重大进展

• 产品发布/开发
• 合併和收购
• 业务扩展
• 伙伴关係和合作关係

第 11 章附录

• 相关研究

Facial Injectables Market Size And Forecast

Facial Injectables Market size was valued at USD 5,746.05 Million in 2021 and is projected to reach USD 23,448.23 Million by 2030 , growing at a CAGR of 16.91% from 2023 to 2030. The most common uses for facial injectables are to alleviate early indications of aging and to enhance aesthetic appeal. Collagens, hyaluronic acids, polymers, and botulinum toxins are some of the most regularly utilized facial injectables. The popularity of face injectable treatment for skin fold reduction, skin smoothening, lip augmentation, wrinkle elimination, acne treatment, scar treatment, and other applications is driving the market adoption of facial injectables. In the following study, the usage of face Injectables for the treatment of paralyzed vocal cords is being considered by the US FDA for approval, which is projected to boost the Facial Injectables Market's growth.

Global Facial Injectables Market Definition

Dermal fillers are another name for facial injectables. Facial injectables include collagen, calcium hydroxyapatite, and hyaluronic acid-based treatments that rejuvenate the facial skin by performing a variety of tasks such as wrinkle removal and reduction, lip enhancement, scar elevating, and soft tissue volume reduction. Filling the target area with facial injectables soothes wrinkles and scars on the face. Anti-wrinkle injections relax the muscles that produce wrinkles, while dermal fillers minimize wrinkles and add volume to the cheeks and lips.

Dermal fillers are injected directly into the wrinkles, while anti-wrinkle injections relax the muscles that generate wrinkles. Fillers are constructed of sugar molecules or hyaluronic acids, collagens (that can come from swine, cows, and cadavers, or be synthesized in a lab), the patient's fat, and synthetic polymers. Calcium hydroxyapatite, polyamide, polyacrylate, and polylactic acid are examples of the latter. The "Artiste Assisted Injection System" was introduced to the US market in 2012 to help in dermal filler distribution.

The injecting device can reduce patient discomfort and adverse events by managing the rate of filling of the injection which is being used by the physician to fill in the lip and frown lines. Bruising, redness, discomfort, and itching are all frequent side effects of a botched dermal filler operation. Infection or allergic reactions are fewer common causes of scarring and tumors. Serious side effects such as blindness from retrograde (abrupt) embolization of the ophthalmic and retinal veins have been reported on a more uncommon basis.

The industry makes use of technological breakthroughs. Antioxidant epidermal patches are now being developed at a high level of innovation. The use of a microneedle on the bottom of the patches penetrates the skin, allowing antioxidants to go deep into the skin. These patches could be a better, faster approach to calming and lightening your skin at home. Patches with better antioxidant penetration will reach their full potential, allowing them to give the wrinkle-smoothing and skin-brightening benefits we want. Providing a variety of future chances for the sector.

Global Facial Injectables Market Overview

The sector has been discovered to be flourishing, with an increase in the size of the Facial Injectables Market. Non-surgical market treatments, facial injectable fillers, and wrinkle relaxer injectables have all seen a three-fold increase. Non-invasive aesthetic procedures will grow the market during the projection period. Skin damage is caused by pollution and numerous lifestyle choices, which drive up demand during the projection period. Collagen fibers, hyaluronic acid fillers, and synthetic fillers are used to make facial injectables. This cream moisturizes and enhances your skin while also protecting it from UV damage and having minimal negative effects.

The market for face injectables is driven by all of the aforementioned criteria. Furthermore, the growing number of plastic surgeons and their networks is driving demand for aesthetic procedures, which is boosting demand for face injectables. There was also FDA authorization for other practitioners, including dentists, to utilize face Injectables in their clinics. Dentists can now perform face injectable procedures because they encounter many patients requiring facial transformation after dental treatments. The market for facial injectables is likely to develop as a result of this.

In addition, advances in treatments and materials, as well as changes in patient demographics, are assisting physicians and dermatologists in treating diverse facial areas. These innovations help physicians and dermatologists create customized treatments for patients and make it easier to use combination products to achieve better outcomes, propelling the worldwide Facial Injectables Market. All of these factors are expected to contribute to the market's future growth. Amplified products like HA (Hyaluronic Acid) and BoNTA (Botulinum Toxin Type A) fillers are used in conjunction to improve outcomes, especially in the lower facial processes.

This also fuels the worldwide Facial Injectables Market's expansion. The capacity of face injectables, major market parameters, year-over-year growth rate, and manufacturer market share are all aspects that influence the industry's opportunities. The growth is restricted by tight regulatory concerns and limits on the items, as well as skin problems such as rashes and redness. Rather than aesthetic applications, the market's expansion will be hampered by several market-hindering factors in the future projection year. Filler prices are too high, limiting expansion and, as a result, market size. The negative effects of dermal fillers are also a major issue limiting the size of the facial injectable business.

Global Facial Injectables Market Segmentation Analysis

The Global Facial Injectables Market is segmented on the basis of Product, Application, and Geography.

Facial Injectables Market, By Product

• Botulinum Toxin Type A
• Calcium Hydroxylapatite (CaHA)
• Collagen
• Hyaluronic Acid (HA)
• Polymer Fillers

Based on Product, the market is bifurcated into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Collagen, Hyaluronic Acid (HA), and Polymer Fillers. The hyaluronic acid segment dominated the market, and it is predicted to increase at a healthy rate over the next few years. The increasing use of hyaluronic acid in the cosmetics industry is likely to fuel growth. Because of its high-water retention qualities and low allergic reactions, hyaluronic acid has become a staple in cosmetics. Hyaluronic acid segment growth includes a moisture-binding feature that helps preserve and enhance the vital moisture held to account for the plumpness of the facial skin. The segment's rise is fuelled by growing demands for cosmetic surgeries and an increase in the number of facial surgeries done.

Facial Injectables Market, By Application

• Therapeutics
• Aesthetics

Based on Application, the market is bifurcated into Therapeutics and Aesthetics. Increasing use of facial injectables for aesthetic procedures such as treatment of parentheses lines, wrinkles on the face, lip lines, lip augmentation, lip border restoration, perioral lines, crow's feet lines, frown lines, glabellar lines, filling furrows (deep wrinkles), periorbital wrinkles, superficial lines, acne scars, tear troughs, marionette lines, lipoatrophy of the face, nasopharyngeal. In the future years, demand for facial injectables for cosmetic purposes is predicted to rise due to a growing interest in physical appearance and income growth among middle-class people in developing nations such as India.

Facial Injectables Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, the Global Facial Injectables Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America led the market in 2020, accounting for more than 41.0 percent of total sales. The high elderly population in the United States and Canada is expected to drive demand for face injectables over the projected period. Botox injections were discovered to have jumped by 845 percent. As a result, in the coming years, North America is likely to be a major income generator for facial injectables. The Asia Pacific market is expected to increase at a quick rate. Among the countries that help the region are India, Australia, and South Korea. In these developing countries, a growing emphasis on physical attractiveness is projected to drive the desire for facial injectable treatments. India is expected to be the largest economy in the world by 2050.

Key Players

• The "Global Facial Injectables Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Suneva Medical Inc., ALLERGAN, Bloomage BioTechnology Corporation Limited, Ipsen, Merz Pharma, Anika Therapeutics Inc., Medytox Inc, Galderma S.A, Prollenium Medical Technologies Inc, Sinclair Pharma.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• The International Society of Aesthetic Plastic Surgery in the United States came in first for non-surgical product discovery. Botulinum toxin and hyaluronic acid were the most well-known injectables identified so far.
• In June 2020, For persons above the age of 21, to reduce wrinkles The FDA granted Allergan Aesthetics approval to develop a variety of cosmetic products. It also acquired FDA approval for the use of hyaluronic acid gel for cheeks to treat age-related disorders from the Food and Drug Administration.
• In August 2018, Antares Pharma and Pfizer Inc. collaborated to develop the rescue pen, an injectable medication device.
• HUMIRA Pen, face injectable fillers, is utilized for human anti-tumor necrosis factor-alpha monoclonal antibodies in the Facial Injectables Market forecast. Patients with rheumatoid arthritis use this injectable medicine, which increases its market demand.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL FACIAL INJECTABLES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL FACIAL INJECTABLES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model

5 GLOBAL FACIAL INJECTABLES MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 Botulinum Toxin Type A
• 5.3 Calcium Hydroxylapatite (CaHA)
• 5.4 Collagen
• 5.5 Hyaluronic Acid (HA)
• 5.6 Polymer Fillers

6 GLOBAL FACIAL INJECTABLES MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Therapeutics
• 6.3 Aesthetics

7 GLOBAL FACIAL INJECTABLES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL FACIAL INJECTABLES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Suneva Medical, Inc.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 ALLERGAN
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Bloomage BioTechnology Corporation Limited
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Ipsen
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Merz Pharma
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Anika Therapeutics, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Medytox, Inc.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Galderma S.A.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Prollenium Medical Technologies Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Sinclair Pharma
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research